Subscribe By RSS or Email
Theralase Could Light Up Cancer Therapeutics

Theralase Could Light Up Cancer Therapeutics

Cancer patients don’t have many good treatment options. Once the disease is detected, most oncologists will surgically remove as much as possible and then use powerful radiation and chemotherapy to kill as many cells in those areas as possible. The side effects from these treatments can be terrible and patients are at a higher risk […]

Exosomes Shine a Light on Alzheimer’s Disease and CTE

Exosomes Shine a Light on Alzheimer’s Disease and CTE

Concussions are common in recreational and professional sports with an estimated 1.6 million sustained concussion-related injuries per year in the U.S. alone. Since concussions aren’t detectable using X-rays or CT scans, they often go undiagnosed and attempts to prevent them have been difficult. These concussions can lead to far more serious problems like chronic traumatic […]

Discovery Could Lead to Major Breakthrough in Alzheimer’s Disease and Other Brain Disorders

Discovery Could Lead to Major Breakthrough in Alzheimer’s Disease and Other Brain Disorders

Some leading scientists are making strides like never before in research for debilitating and deadly diseases, such as Alzheimer’s Disease (AD), Chronic Traumatic Encephalopathy (CTE) and Traumatic Brain Injury (TBI).  Currently, people afflicted with these conditions have little hope to avert disease progression and, sadly, death.  There is reason for optimism, though, with hundreds of […]

Recent Articles:

Lixte Biotech: A Novel Approach to Boost Existing Cancer Therapies

Cellular signaling is a complex system of communication that governs basic cellular activities and coordinates cell actions. In many cases, errors in cellular information processing are responsible for diseases like cancer, autoimmune disorders, and diabetes.

Cleveland Biolabs: A Diverse Play on Both Biodefense and Cancer

The biotechnology industry has significantly outperformed the general market for some time now. So far this year, the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) has jumped nearly 30% compared to a nearly 10% return

Vision-Sciences’ Endoscopy Technology Approaches Tipping Point

The global endoscopy market reached $28.2 billion in 2013 and is expected to grow at a 6.1% CAGR to reach $37.9 billion by 2018, according to Market and Markets. Driven by the growing preference for

Rich Pharmaceuticals: Phase II Clinical Trial Could Provide Catalyst

Many different compounds are constantly being evaluated in the fight to cure cancer, with each one tailored to affect various different types of cells in various parts of the body where cancer exists. TPA –

Targeting the Intersection of Personalized Medicine and Immunology

Personalized medicine and immunology are two of the fastest growing areas of the healthcare industry. By targeting therapeutics based on specific biomarkers, personalized medicine can dramatically improve patient outcomes. Immune-based therapeutics takes the approach a

Heat Biologics Takes a New Approach to Immunotherapy

Immunotherapy leverages the body’s own immune system to fight off diseases ranging from allergies to cancer. For example, Dendreon Corporation’s (NASDAQ: DNDN) PROVENGE therapy takes the patient’s own immune cells and reprograms them to attack

OxySure (OXYS) Merges with Estill Medical Technologies

OxySure Systems Inc. (OTCQB: OXYS), developer of easy-to-use emergency oxygen solutions utilizing its oxygen-from-powder technology, recently announced that it would merge with Estill Medical Technologies Inc., developer of the FDA-cleared Thermal Angel Blood IV Fluid

Accurexa Brings Brain Surgery into the 20th Century

Many people may be surprised to learn that modern brain surgery techniques often rely on a crude syringe invented nearly three decades ago. A patient suffering from Parkinson’s disease may have access to modern breakthroughs

OxySure Systems Selected for USPTO / Smithsonian Innovation Expo

OxySure Systems Inc. (OTCQB: OXYS), developer of life-saving and easy-to-use emergency oxygen solutions leveraging its oxygen from powder technology, recently announced that it was selected by the United States Patent and Trademark Office (“USPTO”) to

Entia Enhances GROH® Reach with Starzz Distribution Agreement

Entia Biosciences Inc. (OTC: ERGO), an emerging leader in the field of nutrigenomics, recently announced a distribution agreement with Shooting Starzz LLC to represent its GROH® product line to over 24,000 salons across the US.

A New Cannabinoid-based Arthritis Therapy in the Making

Cannabinoids have been the focus of intense clinical research following the legalization of medical cannabis by several U.S. states. While pioneers like British-based GW Pharmaceuticals plc (NASDAQ: GWPH) have been actively studying cannabinoids since the 1990s, many

Premier Biomedical Adds Prominent Pathologist to Advisory Board

Premier Biomedical Inc. (OTC: BIEI), a research-based company that intends to discover and develop medical treatments for a wide range of diseases in humans, in collaboration with the University of Texas at El Paso and